SRF/myocardin: a novel molecular axis regulating vascular smooth muscle cell stiffening in hypertension

Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension

(2016) Ning Zhou et al.   CARDIOVASCULAR RESEARCH

Central Artery Stiffness in Hypertension and Aging

(2016) Jay D. Humphrey et al.   CIRCULATION RESEARCH

The Structural Factor of Hypertension: Large and Small Artery Alterations

(2015) S. Laurent et al.   CIRCULATION RESEARCH

Between Rho(k) and a Hard Place: The Relation Between Vessel Wall Stiffness, Endothelial Contractility, and Cardiovascular Disease

(2015) S. Huveneers et al.   CIRCULATION RESEARCH

Inactivation of Serum Response Factor Contributes To Decrease Vascular Muscular Tone and Arterial Stiffness in Mice

(2013) Guillaume Galmiche et al.   CIRCULATION RESEARCH

Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-β–Induced Fibrogenesis in Human Colonic Myofibroblasts

(2013) Laura A. Johnson et al.   INFLAMMATORY BOWEL DISEASES

Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice

(2012) Takeya Minami et al.   EMBO JOURNAL